Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Knapp

Showing results (341-350 of 451) with videos related to

Pageof 46
Sort By:
European Journal of Neurology|December 3, 2003
Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathyPaul McCrone, Daniel Chisholm, Martin Knapp, et al.
BMJ (Clinical Research Ed.)|October 29, 2013
Cost effectiveness of a manual based coping strategy programme in promoting the mental health of family carers of people with dementia (the START (STrAtegies for RelaTives) study): a pragmatic randomised controlled trialMartin Knapp, Derek King, Renee Romeo, et al.
Journal of Clinical Medicine|July 24, 2019
Cost-Utility of Mindfulness-Based Stress Reduction for Fibromyalgia versus a Multicomponent Intervention and Usual Care: A 12-Month Randomized Controlled Trial (EUDAIMON Study)Adrián Pérez-Aranda, Francesco D'Amico, Albert Feliu-Soler, et al.
Trials|July 14, 2014
Improving Well-being and Health for People with Dementia (WHELD): study protocol for a randomised controlled trialRhiannon Whitaker, Jane Fossey, Clive Ballard, et al.
Age and Ageing|February 28, 2013
Effect of telecare on use of health and social care services: findings from the Whole Systems Demonstrator cluster randomised trialAdam Steventon, Martin Bardsley, John Billings, et al.
Schizophrenia Bulletin|April 30, 2014
Schizophrenia--time to commit to policy changeW Wolfgang Fleischhacker, Celso Arango, Paul Arteel, et al.
BMC Health Services Research|June 5, 2026
Costs of autism spectrum disorders and access to services in SpainLidia García-Pérez, Vanesa Ramos-García, Renata Linertová, et al.
BMC Psychiatry|April 18, 2015
Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study)Maria Rubio-Valera, Imma Beneitez, María Teresa Peñarrubia-María, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2023
The worldwide costs of dementia in 2019Anders Wimo, Katrin Seeher, Rodrigo Cataldi, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 24, 2018
Value of schizophrenia treatment II: Decision modelling for developing early detection and early intervention services in the Czech RepublicPetr Winkler, Hana Marie Broulíková, Lucie Kondrátová, et al.
Pageof 46

Showing results (341-350 of 451) with videos related to

Sort By:
Pageof 46
European Journal of Neurology|December 3, 2003
Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathyPaul McCrone, Daniel Chisholm, Martin Knapp, et al.
BMJ (Clinical Research Ed.)|October 29, 2013
Cost effectiveness of a manual based coping strategy programme in promoting the mental health of family carers of people with dementia (the START (STrAtegies for RelaTives) study): a pragmatic randomised controlled trialMartin Knapp, Derek King, Renee Romeo, et al.
Journal of Clinical Medicine|July 24, 2019
Cost-Utility of Mindfulness-Based Stress Reduction for Fibromyalgia versus a Multicomponent Intervention and Usual Care: A 12-Month Randomized Controlled Trial (EUDAIMON Study)Adrián Pérez-Aranda, Francesco D'Amico, Albert Feliu-Soler, et al.
Trials|July 14, 2014
Improving Well-being and Health for People with Dementia (WHELD): study protocol for a randomised controlled trialRhiannon Whitaker, Jane Fossey, Clive Ballard, et al.
Age and Ageing|February 28, 2013
Effect of telecare on use of health and social care services: findings from the Whole Systems Demonstrator cluster randomised trialAdam Steventon, Martin Bardsley, John Billings, et al.
Schizophrenia Bulletin|April 30, 2014
Schizophrenia--time to commit to policy changeW Wolfgang Fleischhacker, Celso Arango, Paul Arteel, et al.
BMC Health Services Research|June 5, 2026
Costs of autism spectrum disorders and access to services in SpainLidia García-Pérez, Vanesa Ramos-García, Renata Linertová, et al.
BMC Psychiatry|April 18, 2015
Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study)Maria Rubio-Valera, Imma Beneitez, María Teresa Peñarrubia-María, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2023
The worldwide costs of dementia in 2019Anders Wimo, Katrin Seeher, Rodrigo Cataldi, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|July 24, 2018
Value of schizophrenia treatment II: Decision modelling for developing early detection and early intervention services in the Czech RepublicPetr Winkler, Hana Marie Broulíková, Lucie Kondrátová, et al.
Pageof 46